Detalhe da pesquisa
1.
Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
Transfusion
; 63(11): 2072-2082, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818894
2.
Platelet aggregation in whole blood is not impaired by a platelet-sparing leukoreduction filter and instead depends upon the presence of leukocytes.
Transfusion
; 61 Suppl 1: S90-S100, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269461
3.
Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology.
Vox Sang
; 116(10): 1076-1083, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835489
4.
Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage.
Transfus Med Hemother
; 46(4): 240-247, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31700506
5.
Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial.
Lancet
; 387(10029): 1753-61, 2016 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27116282
6.
Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood.
Transfusion
; 57(2): 337-348, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859333
7.
Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality.
Transfusion
; 57(8): 2026-2034, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28500654
8.
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies.
Transfusion
; 62(11): 2391-2404, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169155
9.
Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
Transfusion
; 56(12): 2948-2952, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27805261
10.
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
Transfusion
; 56(4): 863-72, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643781
11.
Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Transfusion
; 56(6): 1419-29, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028210
12.
Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients.
Transfusion
; 56(9): 2374-83, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339864
13.
Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.
Transfus Apher Sci
; 54(2): 248-52, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26345109
14.
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
Transfusion
; 55(7): 1745-51, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25702711
15.
Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Transfusion
; 55(4): 858-63, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25438832
16.
Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
Transfusion
; 55(7): 1736-44, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25731607
17.
Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
J Clin Apher
; 30(1): 1-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24941931
18.
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Transfusion
; 53(2): 373-81, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22612327
19.
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
Transfusion
; 53 Suppl 1: 131S-136S, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23301965
20.
Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.
Transfusion
; 53(11): 2697-709, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23451715